Details of the Drug Reposition

General Information of This Drug (ID: DMHPD2Y)

• Drug Name: SODIUM CITRATE (DMHPD2Y)
• Synonyms: Sodium citrate; 68-04-2; TRISODIUM CITRATE; Citrosodine; Sodium citrate anhydrous; Citrosodina; Natrocitral; Citrosodna; Citreme; Citnatin; sodium citrate, anhydrous; Sodium 2-hydroxypropane-1,2,3-tricarboxylate; Trisodium citrate anhydrous; Citric acid, trisodium salt; Trisodium citrate, anhydrous; Citric acid trisodium salt; 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, trisodium salt; UNII-RS7A450LGA; FEMA No. 3026; CCRIS 3293; Sodium citrate (Na3C6H5O7); HSDB 5201; EINECS 200-675-3; RS7A450LGA; CHEBI:53258; Trisodium 2-hydroxy-1
• Drug Type: Small molecular drug

Information on Drug Reposition of This Drug

5 Approved Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Common cold	DIS3MADM	CA00	Approved	[1]
Peptic ulcer	DISL8XZI	DA61	Approved	[1]
Rhinitis	DISKLMN7	FA20	Approved	[1]
Cough	DIS51FA4	MD12	Approved	[1]
Discovery agent	DISC7DFA	N.A.	Approved	[2]

2 Discontinued in Phase 2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Gastroesophageal reflux disease	DISQ8G5S	DA22.Z	Discontinued in Phase 2	[3]
Dyspepsia	DISYEEY6	MD92	Discontinued in Phase 2	[4]

References

• [1] SODIUM CITRATE FDA Label
• [2] Carbonic anhydrase inhibitors. Interaction of isozymes I, II, IV, V, and IX with carboxylates. Bioorg Med Chem Lett. 2005 Feb 1;15(3):573-8.
• [3] Cyproheptadine Hydrochloride and Nutritional Supplementation in Treating Young Patients With Weight Loss With Cancer
• [4] ClinicalTrials.gov (NCT01652014) Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies